Securities code: 000806 securities abbreviation: St Galaxy Announcement No.: 2022-014
Galaxy Biomedical Investment Co.Ltd(000806)
Announcement on the Supreme People’s court rejecting the company’s application for retrial
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Basic information of litigation
The company disclosed Galaxy Biomedical Investment Co.Ltd(000806) (hereinafter referred to as “the company”), Sichuan Yongxing Electronics Co., Ltd. (hereinafter referred to as “Sichuan Yongxing”), Galaxy Tiancheng Group Co., Ltd., Yao Guoping, Pan Qi For details about the case of enterprise loan dispute between Pan Yong and Shanghai Zhuobo Industry Co., Ltd., please refer to the announcement on litigation progress, announcement on litigation progress, announcement on litigation progress and relevant major risks, announcement on the progress of fund occupation and illegal guarantee of the original actual controller disclosed by the company Announcement on receiving the acceptance notice of applying for retrial to the Supreme People’s Court (Announcement No.: 2019-021, 2020-056, 2021-068, 2021-110, 2021-115).
2、 Progress of application for retrial of litigation cases
Recently, the company received the civil ruling ((2021) supreme law min Shen No. 7588) made by the Supreme People’s court. The Supreme People’s court has ruled on the retrial application of the company and Sichuan Yongxing:
Reject the retrial application of Galaxy Biomedical Investment Co.Ltd(000806) and Sichuan Yongxing Electronics Co., Ltd. 3、 Impact on the company’s current or future profits
The company has accrued 322 million estimated liabilities for the lawsuit, which has a great impact on the owner’s equity in 2021.
The information disclosure media designated by the company are securities times, securities daily and cninfo（ http://www.cn.info.com.cn. ）, the relevant information of the company shall be subject to the announcement published in the above designated information disclosure media. Please pay attention to the relevant announcement of the company. The company and all members of the board of directors guarantee that the content of information disclosure is true, accurate and complete without false records, misleading statements or major omissions. Please invest rationally and pay attention to investment risks.
4、 Documents for future reference
The civil ruling (2021) supreme law min Shen No. 7588 is hereby announced.
Galaxy Biomedical Investment Co.Ltd(000806) board of directors
February 17, 2002
